目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Market Definitions
1.1.2 Estimates And Forecast Timeline
1.2 Objectives
1.2.1 Objective - 1
1.2.2 Objective - 2
1.2.3 Objective - 3
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Epidemiology-Based Market Analysis
1.7.1.1 Approach 1: Epidemiology-Based Approach
1.7.1.2 Approach 2: Commodity Flow Approach
1.7.1.3 Approach 2: Revenue share analysis Using Bottom-up Approach
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Research Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 By Type and Route of Administration Snapshot
2.3 By Distribution Channel Segment Snapshot
2.4 Competitive Landscape Snapshot

Chapter 3 Anti-infective Agents Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Incidence Of Targeted Diseases
3.2.1.2 Growing Investments On R&D Activities Of Anti-Infective Drugs
3.2.1.3 Rise In Initiatives For The Awareness Of Infectious Diseases
3.2.2 Market Restraint Analysis
3.2.2.1 Emergence of Resistance to Anti-infective Drugs and Adverse Effects Associated with them
3.3 Anti-infective Agents Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestle Analysis

Chapter 4 Anti-infective Agents Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
4.1 Anti-infective Agents Market: Type Movement Analysis
4.2 Anti-infective Agents Market Estimates & Forecast, By Type (USD Million)
4.2.1 Antibacterials
4.2.1.1 Cephalosporins
4.2.1.2 Penicillin
4.2.1.3 Fluoroquinolones
4.2.1.4 Macrolides
4.2.1.5 Carbapenem
4.2.1.6 Others
4.2.2 Antivirals
4.2.3 Antifungals
4.2.3.1 Azoles
4.2.3.2 Echinocandins
4.2.3.3 Polyenes
4.2.3.4 Others

Chapter 5 Anti-infective Agents Market - Segment Analysis, by Route of Administration, 2018 - 2030 (US Million)
5.1 Anti-infective Agents Market: Route of Administration Movement Analysis
5.2 Anti-infective Agents Market Estimates & Forecast, By Route of Administration (USD Million)
5.2.1 Topical
5.2.2 Oral
5.2.3 Parental
5.2.4 Others

Chapter 6 Anti-infective Agents Market - Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Mllion)
6.1 Anti-infective Agents Market: Distribution Channel Movement Analysis
6.2 Anti-infective Agents Market Estimates & Forecast, By Distribution Channel (USD Million)
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Others

Chapter 7 Anti-infective Agents Market: Regional Estimates and Trend Analysis by Type, Route of Administration, and Distribution Channel
7.1 Anti-infective Agents Market: Regional Outlook
7.2 North America
7.2.1 North America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 U.S. Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2.3 Competitive/Market Scenario
7.2.2.4 Regulatory Framework
7.2.2.5 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Key Country Dynamics
7.2.3.2 Canada Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3.3 Competitive/Market Scenario
7.2.3.4 Regulatory Framework
7.2.3.5 Reimbursement Scenario
7.2.4 Mexico
7.2.4.1 Key Country Dynamics
7.2.4.2 Mexico Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4.3 Competitive/Market Scenario
7.2.4.4 Regulatory Framework
7.2.4.5 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.2 UK
7.3.2.1 Key Country Dynamics
7.3.2.2 UK Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2.3 Competitive/Market Scenario
7.3.2.4 Regulatory Framework
7.3.2.5 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Key Country Dynamics
7.3.3.2 Germany Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3.3 Competitive/Market Scenario
7.3.3.4 Regulatory Framework
7.3.3.5 Reimbursement Scenario
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 France Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4.3 Competitive/Market Scenario
7.3.4.4 Regulatory Framework
7.3.4.5 Reimbursement Scenario
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Italy Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5.3 Competitive/Market Scenario
7.3.5.4 Regulatory Framework
7.3.5.5 Reimbursement Scenario
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Spain Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6.3 Competitive/Market Scenario
7.3.6.4 Regulatory Framework
7.3.6.5 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Key Country Dynamics
7.3.7.2 Denmark Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7.3 Competitive/Market Scenario
7.3.7.4 Regulatory Framework
7.3.7.5 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Key Country Dynamics
7.3.8.2 Sweden Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8.3 Competitive/Market Scenario
7.3.8.4 Regulatory Framework
7.3.8.5 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Key Country Dynamics
7.3.9.2 Norway Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9.3 Competitive/Market Scenario
7.3.9.4 Regulatory Framework
7.3.9.5 Reimbursement Scenario
7.3.10 Rest Of Europe Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Japan Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2.3 Competitive/Market Scenario
7.4.2.4 Regulatory Framework
7.4.2.5 Reimbursement Scenario
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 China Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3.3 Competitive/Market Scenario
7.4.3.4 Regulatory Framework
7.4.3.5 Reimbursement Scenario
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 India Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4.3 Competitive/Market Scenario
7.4.4.4 Regulatory Framework
7.4.4.5 Reimbursement Scenario
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Australia Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5.3 Competitive/Market Scenario
7.4.5.4 Regulatory Framework
7.4.5.5 Reimbursement Scenario
7.4.6 Thailand
7.4.6.1 Key Country Dynamics
7.4.6.2 Thailand Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6.3 Competitive/Market Scenario
7.4.6.4 Regulatory Framework
7.4.6.5 Reimbursement Scenario
7.4.7 South Korea
7.4.7.1 Key Country Dynamics
7.4.7.2 South Korea Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7.3 Competitive/Market Scenario
7.4.7.4 Regulatory Framework
7.4.7.5 Reimbursement Scenario
7.4.8 Rest Of Asia Pacific Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Brazil Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2.3 Competitive/Market Scenario
7.5.2.4 Regulatory Framework
7.5.2.5 Reimbursement Scenario
7.5.3 Argentina
7.5.3.1 Key Country Dynamics
7.5.3.2 Argentina Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3.3 Competitive/Market Scenario
7.5.3.4 Regulatory Framework
7.5.3.5 Reimbursement Scenario
7.5.4 Rest Of Latin America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 Key Country Dynamics
7.6.2.2 South Africa Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2.3 Competitive/Market Scenario
7.6.2.4 Regulatory Framework
7.6.2.5 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Key Country Dynamics
7.6.3.2 Saudi Arabia Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3.3 Competitive/Market Scenario
7.6.3.4 Regulatory Framework
7.6.3.5 Reimbursement Scenario
7.6.4 UAE
7.6.4.1 Key Country Dynamics
7.6.4.2 UAE Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4.3 Competitive/Market Scenario
7.6.4.4 Regulatory Framework
7.6.4.5 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Key Country Dynamics
7.6.5.2 Kuwait Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5.3 Competitive/Market Scenario
7.6.5.4 Regulatory Framework
7.6.5.5 Reimbursement Scenario
7.6.6 Rest Of MEA Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape
8.1 Participant Categorization
8.2 Participant's Overview
8.3 Financial Performance
8.4 Product Benchmarking
8.5 Company Market Positioning Analysis, 2024
8.6 Key Company Profiles
8.6.1. Pfizer Inc.
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Bayer AG
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. AbbVie
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Gilead Sciences, Inc.
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Bristol-Myers Squibb
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Merck & Co., Inc.
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Sandoz International GmbH
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. B. Braun SE
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Xellia Pharmaceuticals
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. Mankind Pharma
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. AstraZeneca
8.6.11.1. Company overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives
8.6.12. Boehringer Ingelheim International GmbH
8.6.12.1. Company overview
8.6.12.2. Financial performance
8.6.12.3. Product benchmarking
8.6.12.4. Strategic initiatives

Chapter 9 Conclusion

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
Table 4 North America Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 5 North America Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 6 North America Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 7 U.S. Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 8 U.S. Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 9 U.S. Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 10 Canada Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 11 Canada Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 12 Canada Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Mexico Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 14 Mexico Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 15 Mexico Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Europe Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
Table 17 Europe Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 18 Europe Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 Europe Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 UK Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 21 UK Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 UK Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Germany Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 24 Germany Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 25 Germany Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 France Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 27 France Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 28 France Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Spain Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 30 Spain Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 Spain Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Italy Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 33 Italy Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 34 Italy Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Denmark Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 36 Denmark Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 37 Denmark Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Sweden Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 39 Sweden Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 40 Sweden Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Norway Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 42 Norway Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Norway Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Japan Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 49 Japan Anti-Infective Agents Market, By Route of Administration 2018 - 2030 (USD Million)
Table 50 Japan Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 51 China Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 52 China Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 53 China Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 54 India Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 55 India Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 56 India Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 57 South Korea Anti-Infective Agents Market, By Type 2018 - 2030 (USD Million)
Table 58 South Korea Anti-Infective Agents Market, By Route of Administration 2018 - 2030 (USD Million)
Table 59 South Korea Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Australia Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 61 Australia Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 62 Australia Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Thailand Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 64 Thailand Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 65 Thailand Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Latin America Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
Table 67 Latin America Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 68 Latin America Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 69 Latin America Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 70 Brazil Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 71 Brazil Anti-Infective Agents Market, By Route of Administration 2018 - 2030 (USD Million)
Table 72 Brazil Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Argentina Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 74 Argentina Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 Argentina Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa Anti-Infective Agents Market, By Country, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 South Africa Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 81 South Africa Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 82 South Africa Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 86 UAE Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 87 UAE Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 88 UAE Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 89 Kuwait Anti-Infective Agents Market, By Type, 2018 - 2030 (USD Million)
Table 90 Kuwait Anti-Infective Agents Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Kuwait Anti-Infective Agents Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research approaches
Fig. 2 Value chain-based sizing & forecasting
Fig. 3 Market formulation & validation
Fig. 4 Anti-Infective Agents market segmentation
Fig. 5 Market driver analysis (current & future impact)
Fig. 6 Market restraint analysis (current & future impact)
Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 8 Porter’s five forces analysis
Fig. 9 Anti-Infective Agents market: Type outlook and key takeaways
Fig. 10 Anti-Infective Agents market: Type movement analysis
Fig. 11 Antibacterials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 12 Antivirals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Antifungals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Cephalosporins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Penicillins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Fluoroquinolones market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Macrolides market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Carbapenems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Azoles market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Echinocandins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Polyenes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Anti-Infective Agents market: Route of administration outlook and key takeaways
Fig. 24 Anti-Infective Agents market: Route of administration movement analysis
Fig. 25 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Anti-Infective Agents market: Distribution channel outlook and key takeaways
Fig. 28 Anti-Infective Agents market: Distribution channel movement analysis
Fig. 29 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Research Centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 North America Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 U.S. Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Canada Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Mexico Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Europe Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.K. Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Germany Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 France Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Italy Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Spain Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Denmark Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Sweden Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Norway Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 China Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 India Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Australia Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Thailand Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 South Korea Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Latin America Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Brazil Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Argentina Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 MEA Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Africa Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 UAE Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Kuwait Anti-Infective Agents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 List of key emerging company’s/disruptors/innovators